Synchrotron Radiation Rotational RadioTherapy for Breast Cancer
Project Acronym: SR3T
Starting date: 01/01/2018
Duration in Months: 36
Principal Investigator: Giovanni Mettivier, PhD
Objective: To propose and investigate an innovative therapeutic approach for breast cancer therapy which combines kilovoltage external beam rotational radiotherapy using synchrotron radiation, the use of contrast and radiosensitizing agents, image guidance via pre-treatment and within-treatment computed tomography scans for precise tumor localization and patient repositioning, showing its potential with respect to currently available conventional and experimental radiotherapy techniques for breast cancer.
Abstract
Radiotherapy is normally delivered using high-energy MeV photon beams produced by clinical accelerators. Radiation therapy of breast cancer may benefit from recent experimental investigations in tumor radiotherapy with kilovoltage photon beams produced by orthovoltage X-ray tubes. We propose to adopt monoenergetic or polyenergetic beams at photon energies below @ 200 keV down to @ 60 keV for breast cancer rotational radiotherapy, either fully opened to irradiate the whole breast, or suitably collimated to irradiate at least part of the tumor volume, then scanned across that volume in a fully tomographic rotate-and-translate geometry. The source for such an experimental technique is a medium-energy synchrotron radiation. In this new technique, termed synchrotron radiation rotational radiotherapy (SR3T), the patient is in prone position on a bed containing a hole through which the uncompressed breast hangs inside a holder. The bed is rotated over 360 deg around a vertical axis centered at the tumor site, with the beam suitably collimated in the horizontal and vertical directions, so as to irradiate, in the horizontal plane, the whole breast or just a thin tumor slice. The bed is then translated vertically and another slice of the target volume is irradiated in a successive full rotation: after a suitable number of rotations (with possibly laterally displaced vertical axes of rotation), all the target volume may receive the planned dose. Preliminary Monte Carlo investigations and experimental validations recently performed by the proponents indicated that ─ by the principle of rotational summation of dose at the axis of rotation ─ the almost exponentially decreasing trend of the absorbed dose with radial depth in the medium characteristic of the single-irradiation angle, turns into a dose distribution peaked at the axis of rotation, where the target volume is located. This produces an inversion of the percentage depth dose curve, with less dose at the organ surface than at the tumor site, assuring similar values of the skin sparing as with conventional accelerator based breast radiotherapy with two 180-deg angled beams tangential to the chest wall, due to the presence of the build-up region for megavoltage beams (15 mm maximum dose depth at 6 MV in water). This three-year project proposes to carry out Geant4 Monte Carlo simulations and experimental validations in breast phantoms at synchrotron radiation facilities, for assessing the merits of the SR3T technique, in terms of 3D dose distributions and tumor-to-skin dose ratio, cell culture studies for cell killing action at kilovoltage photon energies, possible use of iodinated contrast agents and metal nanoparticles as radiosensitizing agents, optimal energy selection, full target volume coverage, identification of basic parameters for a future treatment planning system at synchrotron radiation facilities.
Project Highlights:
- Breast radiotherapy with kilovoltage X-ray beams
- dose enhanced radiotherapy with iodinated agent
- Rotational irradiation in full tomotherapy for skin sparing without buildup
- Online image guided breast CT
- Collimated beam or pencil beam scanning for dose painting
- Contrast enhanced CT